176 related articles for article (PubMed ID: 37114499)
1. A carbon dot-doped Cu-MOF-based smart nanoplatform for enhanced immune checkpoint blockade therapy and synergistic multimodal cancer therapy.
Su Z; Xu H; Zhang Y; Zhang H; Zhang H; Bao Y; Wu X; Yan R; Tan G; Wang Z; Jin Y
J Mater Chem B; 2023 May; 11(19):4211-4226. PubMed ID: 37114499
[TBL] [Abstract][Full Text] [Related]
2. Key Modulation of ROS and HSP for Effective Therapy Against Hypoxic Tumor with Multifunctional Nanosystem.
Ma B; Zhao Y; Liu X; Huo M; Wang J; Ma J; Zhang Y; Qin C
Int J Nanomedicine; 2023; 18():6829-6846. PubMed ID: 38026539
[TBL] [Abstract][Full Text] [Related]
3. Cu
Xu H; Su Z; Zhang H; Zhang Y; Bao Y; Zhang H; Wu X; Yan R; Wang Z; Jin Y
Int J Pharm; 2023 Jun; 640():123002. PubMed ID: 37254284
[TBL] [Abstract][Full Text] [Related]
4. A metal-organic framework (MOF) built on surface-modified Cu nanoparticles eliminates tumors via multiple cascading synergistic therapeutic effects.
An G; Zheng H; Guo L; Huang J; Yang C; Bai Z; Wang N; Yang W; Zhu Y
J Colloid Interface Sci; 2024 May; 662():298-312. PubMed ID: 38354557
[TBL] [Abstract][Full Text] [Related]
5. Cu-MOF chemodynamic nanoplatform via modulating glutathione and H
Tian H; Zhang M; Jin G; Jiang Y; Luan Y
J Colloid Interface Sci; 2021 Apr; 587():358-366. PubMed ID: 33360905
[TBL] [Abstract][Full Text] [Related]
6. Covalent organic frameworks-derived carbon nanospheres based nanoplatform for tumor specific synergistic therapy via oxidative stress amplification and calcium overload.
Pang Y; Lv J; He C; Ju C; Lin Y; Zhang C; Li M
J Colloid Interface Sci; 2024 May; 661():908-922. PubMed ID: 38330663
[TBL] [Abstract][Full Text] [Related]
7. Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma.
Xu J; Zheng Q; Cheng X; Hu S; Zhang C; Zhou X; Sun P; Wang W; Su Z; Zou T; Song Z; Xia Y; Yi X; Gao Y
J Nanobiotechnology; 2021 Oct; 19(1):355. PubMed ID: 34717654
[TBL] [Abstract][Full Text] [Related]
8. A prodrug hydrogel with tumor microenvironment and near-infrared light dual-responsive action for synergistic cancer immunotherapy.
Ding M; Fan Y; Lv Y; Liu J; Yu N; Kong D; Sun H; Li J
Acta Biomater; 2022 Sep; 149():334-346. PubMed ID: 35779775
[TBL] [Abstract][Full Text] [Related]
9. In-situ fabrication of novel Au nanoclusters-Cu
Yang Z; Zhao Z; Cheng H; Shen Y; Xie A; Zhu M
J Colloid Interface Sci; 2023 Jul; 641():215-228. PubMed ID: 36933468
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable Poly(γ-glutamic acid)@glucose oxidase@carbon dot nanoparticles for simultaneous multimodal imaging and synergetic cancer therapy.
Zhang M; Wang W; Wu F; Zheng T; Ashley J; Mohammadniaei M; Zhang Q; Wang M; Li L; Shen J; Sun Y
Biomaterials; 2020 Sep; 252():120106. PubMed ID: 32417651
[TBL] [Abstract][Full Text] [Related]
11. NIR-II-driven and glutathione depletion-enhanced hypoxia-irrelevant free radical nanogenerator for combined cancer therapy.
Zhang L; Fan Y; Yang Z; Yang M; Wong CY
J Nanobiotechnology; 2021 Sep; 19(1):265. PubMed ID: 34488803
[TBL] [Abstract][Full Text] [Related]
12. A tumor pH-responsive autocatalytic nanoreactor as a H
Liu F; He T; Gong S; Shen M; Ma S; Huang X; Li L; Wang L; Wu Q; Gong C
Acta Biomater; 2022 Dec; 154():510-522. PubMed ID: 36241016
[TBL] [Abstract][Full Text] [Related]
13. Enzyme-like copper-encapsulating magnetic nanoassemblies for switchable T1-weighted MRI and potentiating chemo-/photo-dynamic therapy.
Li T; Rao B; Xu D; Zhou J; Sun W; Zhi X; Zhang C; Cui D; Xu H
Acta Biomater; 2022 Nov; 153():431-441. PubMed ID: 36174937
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional Nanoparticles-Mediated PTT/PDT Synergistic Immune Activation and Antitumor Activity Combined with Anti-PD-L1 Immunotherapy for Breast Cancer Treatment.
Kong C; Xu B; Qiu G; Wei M; Zhang M; Bao S; Tang J; Li L; Liu J
Int J Nanomedicine; 2022; 17():5391-5411. PubMed ID: 36419717
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional MnO
Wang Q; Qu B; Li J; Liu Y; Dong J; Peng X; Zhang R
ACS Appl Mater Interfaces; 2022 Feb; 14(4):4980-4994. PubMed ID: 35050589
[TBL] [Abstract][Full Text] [Related]
16. Prussian Blue-Derived Nanoplatform for In Situ Amplified Photothermal/Chemodynamic/Starvation Therapy.
Liang J; Sun Y; Wang K; Zhang Y; Guo L; Bao Z; Wang D; Xu H; Zheng J; Yuan Y
ACS Appl Mater Interfaces; 2023 Apr; 15(14):18191-18204. PubMed ID: 36975190
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of dual-stimuli responsive metal organic framework-coated iridium oxide nanocomposite functionalized with tumor targeting albumin-folate for synergistic photodynamic/photothermal cancer therapy.
Deng X; Zhao R; Song Q; Zhang Y; Zhao H; Hu H; Zhang Z; Liu W; Lin W; Wang G
Drug Deliv; 2022 Dec; 29(1):3142-3154. PubMed ID: 36164704
[TBL] [Abstract][Full Text] [Related]
18. Organic disulfide-modified folate carbon dots for tumor-targeted synergistic chemodynamic/photodynamic therapy.
Tang S; Li G; Zhang H; Bao Y; Wu X; Yan R; Wang Z; Jin Y
Biomater Sci; 2023 May; 11(9):3128-3143. PubMed ID: 36919663
[TBL] [Abstract][Full Text] [Related]
19. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
[TBL] [Abstract][Full Text] [Related]
20. Open-Source and Reduced-Expenditure Nanosystem with ROS Self-Amplification and Glutathione Depletion for Simultaneous Augmented Chemodynamic/Photodynamic Therapy.
Chen M; Zhao S; Zhu J; Feng E; Lv F; Chen W; Lv S; Wu Y; Peng X; Song F
ACS Appl Mater Interfaces; 2022 May; 14(18):20682-20692. PubMed ID: 35500204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
